FDA-Cleared Blood Test for Alzheimer’s Assessment in Primary Care Now Available Nationwide
The Elecsys pTau-181 test helps primary care clinicians rule out Alzheimer's disease in symptomatic patients aged 55 and older.
Latest Articles
Editor's Top Picks
What Clinical Lab Leaders Predict for 2026
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
FDA Grants Breakthrough Device Designation for Hemoglobin Variant Test
The test uses miniaturized electrophoresis technology designed to enable decentralized access to quantitative hemoglobin data.
Equipment & Supply Spotlight
FDA Warns of False Positive Lead Test Results with Certain Blood Collection Tubes
The FDA has warned of falsely elevated lead test results when using ASP Global’s SAFE-T-FILL tubes with Magellan Diagnostics LeadCare systems and has issued warning letters to involved manufacturers.
News, Know-How & Standards
Disease Detection & Understanding
Blood Test Detects Early-Stage Cancer Using DNA Methylation Patterns
Johns Hopkins researchers have developed a liquid biopsy that detects early-stage lung and breast cancers by measuring DNA methylation variation, showing high accuracy in a study published in Clinical Cancer Research.
